The Latest Breaking News from Pfizer

Stock market indexes took a tumble Monday after Moody's Investor's Service cut its rating on U.S. debt. Boeing surged on deal news.

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Amid this, let’s analyze the fundamentals of AbbVie (ABBV) and Pfizer (PFE) to determine whether these stocks are worth buying now.

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

Tesla was one of several industrial companies in the top five, while Pfizer and energy giants Chevron and ExxonMobil also put up big numbers.

Roche said Monday it would buy an experimental immunology drug from Roivant and Pfizer for $7.1 billion. But ROIV stock sank.

Pfizer & KIMS Hospital in Hyderabad inaugurated a CoE for Adult Vaccination to equip HCPs & educate patients on enduring advantages of vaccinations. It will reinforce immunisation against Pneumococcal, Hepatitis A/B, HPV & Influenza. CoE symbolises commitment to protecting individuals against respiratory threats & enhancing quality of life.

The fallout from the Israel-Hamas war has spilled into workplaces everywhere, with corporate leaders from the highest ranks of prominent companies weighing in with their views while workers complain their voices are not being heard

One of the most effective treatments for COVID is going to get a lot more expensive, but Pfizer insists it's fine

Pfizer is hiking its Paxlovid price to $1,390 for a five-day course of the Covid pill. But Pfizer stock fell early Thursday.